Evaluation of Safety and Efficacy of Intrastromal Implantation of CorVision® Bioengineered Corneal Inlay for Correction of Presbyopia.

NAActive, not recruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

March 25, 2020

Primary Completion Date

September 25, 2022

Study Completion Date

June 30, 2026

Conditions
Presbyopia
Interventions
DEVICE

Intrastromal implantation of CorVision bioengineered corneal inlay for correction of presbyopia.

Presbyopia is an age-related progressive loss of crystalline lens accommodation power resulting in the decreased ability to see near objects. CorVision® is a tissue-mimetic device primarily intended to be used as a corneal inlay in the management of presbyopia and low hypermetropia. The inlay is inserted into the patient's cornea via a minimally invasive laser pocket procedure to modify corneal surface topography and corneal optical performance.

Trial Locations (1)

760 01

Gemini Eye Clinics, Zlín

Sponsors
All Listed Sponsors
lead

LinkoCare Life Sciences AB

INDUSTRY